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Abstract. 
 
Agrin released from motor nerve terminals 
activates a muscle-speciﬁc receptor tyrosine kinase 
(MuSK) in muscle cells to trigger formation of the skel-
etal neuromuscular junction. A key step in synaptogen-
esis is the aggregation of acetylcholine receptors 
(AChRs) in the postsynaptic membrane, a process that 
requires the AChR-associated protein, rapsyn. Here, 
we mapped domains on MuSK necessary for its interac-
 
tions with agrin and rapsyn. Myotubes from 
 
MuSK
 
2
 
/
 
2
 
 
mutant mice form no AChR clusters in response to 
agrin, but agrin-responsiveness is restored by the intro-
 
duction of rat MuSK or a 
 
Torpedo
 
 orthologue. Thus, 
 
MuSK
 
2
 
/
 
2
 
 myotubes provide an assay system for the 
structure–function analysis of MuSK. Using this sys-
tem, we found that sequences in or near the ﬁrst of four 
extracellular immunoglobulin-like domains in MuSK 
are required for agrin responsiveness, whereas se-
quences in or near the fourth immunoglobulin-like do-
main are required for interaction with rapsyn. Analysis 
of the cytoplasmic domain revealed that a recognition 
site for the phosphotyrosine binding domain–contain-
ing proteins is essential for MuSK activity, whereas
consensus binding sites for the PSD-95/Dlg/ZO-1-like 
domain–containing proteins and phosphatidylinositol-
3-kinase are dispensable. Together, our results indicate 
that the ectodomain of MuSK mediates both agrin-
dependent activation of a complex signal transduction 
pathway and agrin-independent association of the ki-
nase with other postsynaptic components. These inter-
actions allow MuSK not only to induce a multimolecu-
lar AChR-containing complex, but also to localize that 
complex to a primary scaffold in the postsynaptic mem-
brane.
Key words: MuSK • acetylcholine receptors • neuro-
muscular junction • synapse • agrin
 
D
 
URING
 
 formation of the vertebrate neuromuscular
junction, motor axons release the proteoglycan
agrin to trigger differentiation of the underlying
postsynaptic membrane (McMahan, 1990; Gautam et al.,
1996; Cohen et al., 1997; Jones et al., 1997; Burgess et
 
al., 1999; for review see Burden, 1998; Sanes and Lichtman,
 
1999). The best studied step in this program of differentiation
is the aggregation of acetylcholine receptors (AChRs)
 
1
 
 di-
rectly beneath the nerve terminal. An effector of the ag-
gregation process is a cytoplasmic AChR-associated pro-
tein called rapsyn; rapsyn induces aggregation of AChRs
when both are expressed in heterologous cells, and no
AChR clusters form in mutant mice that lack rapsyn
(Froehner et al., 1990; Phillips et al., 1991a,b; Apel et al.,
1995; Gautam et al., 1995). Thus, agrin may act in part by
promoting interactions of AChRs with rapsyn.
A critical component in the signal transduction pathway
that leads from agrin to rapsyn is a muscle-specific recep-
tor tyrosine kinase called MuSK (Valenzuela et al., 1995).
MuSK is concentrated, along with AChRs and rapsyn, in
the postsynaptic apparatus. Although agrin can interact
with numerous components on the myotube surface (for
 
review see Sanes et al., 1998), MuSK became the lead-
ing  candidate agrin receptor with the observation that
 
MuSK
 
2/2
 
 mice, like 
 
agrin
 
2
 
/
 
2
 
 and 
 
rapsyn
 
2
 
/
 
2
 
 
 
mice, fail to
form neuromuscular junctions (deChiara et al., 1996). Sub-
sequent studies in vitro supported MuSK’s candidacy:
agrin rapidly stimulated MuSK phosphorylation in cul-
tured myotubes; the introduction of a dominant negative
mutant MuSK inhibited agrin’s ability to form AChR clus-
ters; only isoforms or fragments of agrin that activated
MuSK induced AChR clustering; and chemical cross-link-
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1. 
 
Abbreviations used in this paper: 
 
AChR, acetylcholine receptor; MASC,
muscle-associated specificity component; MuSK, muscle-specific receptor
tyrosine kinase; PDZ, PSD-95/Dlg/ZO-1-like; PTB, phosphotyrosine-
binding; RATL, rapsyn-associated transmembrane linking molecule;
 
rBTX, rhodamine-
 
a
 
-bungarotoxin. 
The Journal of Cell Biology, Volume 146, 1999 1134
 
ing showed specific interaction of agrin with MuSK (Glass
et al., 1996, 1997; Meier et al., 1996; Fuhrer et al., 1997;
Hopf and Hoch, 1998a,b).
Although genetic and biochemical evidence has estab-
lished MuSK as a component of the agrin receptor, it re-
mains unclear how agrin interacts with MuSK and how
MuSK interacts with rapsyn. Agrin can be cross-linked to
MuSK on the surface of myotubes, but direct binding of
agrin to purified MuSK has not been demonstrable,
suggesting that an accessory component (called MASC,
for muscle-associated specificity component; Glass et al.,
1996) is required. Moreover, MuSK is unusual among re-
ceptor tyrosine kinases in that ligand-dependent activation
is insufficient to mediate its effects: a chimera composed of
the neurotrophin receptor (trkC kinase) ectodomain fused
to the MuSK cytoplasmic domain is activated by neurotro-
phin, but does not induce AChR clustering (Glass et al.,
1997; Jones et al., 1999). Thus, the MuSK ectodomain ap-
pears to play roles in addition to that of ligand binding.
One possible role is the interaction of MuSK with rapsyn.
Indeed, although MuSK and rapsyn cocluster in heterolo-
gous cells (Gillespie et al., 1996), this association requires
extracellular MuSK sequences, suggesting that the ecto-
domain interacts with a rapsyn-associated transmembrane
linking molecule (RATL; Apel et al., 1997). By virtue of
this linkage, AChR–rapsyn complexes could be induced
by and become associated with agrin/MASC/MuSK com-
plexes, thereby forming a postsynaptic apparatus.
To begin to understand how MuSK functions, we
wanted to define critical regions of its extracellular and cy-
toplasmic domains. To this end, we devised an assay sys-
tem using a myogenic cell line derived from 
 
MuSK
 
2
 
/
 
2
 
mice. Agrin did not induce AChR clustering in 
 
MuSK
 
2
 
/
 
2
 
myotubes, but agrin sensitivity was restored by introduc-
tion of wild-type MuSK. Therefore, we were able to test
the ability of a series of mutant MuSK constructs to induce
AChR clustering and to coaggregate with rapsyn and
AChRs. We show that distinct portions of the MuSK
ectodomain are necessary for interactions with agrin/
MASC and rapsyn/RATL. Within the cytoplasmic do-
main, a recognition site for phosphotyrosine binding (PTB)
domain–containing proteins is essential for activity,
whereas a recognition site for PSD-95/Dlg/ZO-1-like (PDZ)
domain–containing proteins is dispensable. Based on these
and previous results, we propose a model in which the
ectodomain of MuSK not only mediates ligand-dependent
activation of a complex signal transduction pathway, but
also directs ligand-independent localization of a multi-
molecular AChR-containing complex to the postsynaptic
membrane.
 
Materials and Methods
 
Mutagenesis of MuSK
 
Expression vectors encoding rat MuSK, rat trkC, and a rat MuSK-rat trkC
chimera were described previously (Apel et al., 1997). In all three vectors,
the cDNA is expressed under the control of the Rous Sarcoma virus long
terminal repeat. In the chimera, the extracellular domain of MuSK except
for the last three amino acids before the predicted transmembrane do-
main (amino acids 1–492) is followed by 32 amino acids of the extracellu-
lar domain plus the complete transmembrane and cytoplasmic domains of
rat trkC. In the trkC and MuSK-trkC constructs, a myc tag consisting of
 
three tandem copies of a 12–amino acid myc epitope was fused in-frame at
the carboxy-terminal of the coding region.
MuSK and the MuSK-trkC chimera are called construct 1 and con-
struct 1T, respectively. Constructs 2–6 are identical to construct 1, and
constructs 2T, 5T, 6T, 14T, and 15T are identical to construct 1T except
that in each case a fragment of MuSK was deleted. Deletions, constructed
by PCR, were as follows: 2 and 2T, amino acids 25–112, inclusive; 3, amino
acids 115–204; 4, amino acids 205–299; 5 and 5T, amino acids 299–396; 6
and 6T, amino acids 397–484; 14T, 25–204; and 15T, amino acids 25–299.
Constructs 7–13 were derived from a vector in which the rat MuSK
cDNA was expressed under the control of late adenovirus promoter, and
a Srf I site was engineered in-frame just upstream of the transmembrane
domain. Deletions were constructed by PCR, removing successively larger
fragments of the ectodomain as follows: 7, amino acids 447–492; 8, amino
acids 398–492; 9, amino acids 283–492; 10, 233–492; 11, amino acids 191–
492; 12, amino acids 142–492; and 13, amino acids 99–492.
In constructs 16–25, the ectodomain of MuSK was intact, but portions
of the cytoplasmic domain were mutated or deleted. The mutations, gen-
erated by mutagenesis, were as follows: 16, Lys608 was replaced by Ala;
17, Tyr553 was replaced by Phe; 18, Asp545-Arg546-Leu547-His548 and
Pro549 were replaced by Leu-Tyr-Leu-Ser-Ser; 19, amino acids 545–549
were replaced by Ile-Pro-Ile-Leu-Glu; 24, Tyr831 was replaced by Phe;
and 25, Val866 Gly867 and Val868 were deleted. The deletions, con-
structed by PCR, were as follows: construct 20, amino acids 515–594, in-
clusive; 21, amino acids 655–868; 22, amino acids 721–868; and construct
23, amino acids 799–868.
The coding sequence of a tyrosine kinase from 
 
Torpedo
 
 electric organ
(Jennings et al., 1993) was inserted in place of rat MuSK in construct 7. In
all constructs, ligation junctions were sequenced to confirm correct inser-
tion and maintenance of the reading frame.
 
Cell Culture
 
MuSK
 
1
 
/
 
2
 
 mice were bred with transgenic mice bearing a temperature-sen-
sitive SV40 T antigen under the control of an interferon-inducible pro-
moter (Jat et al., 1991). 
 
MuSK
 
1
 
/
 
2
 
, transgene-positive offspring were back-
crossed to 
 
MuSK
 
1
 
/
 
2
 
 
 
mice and a myogenic line was established from
hindlimb muscles of a 
 
MuSK
 
2
 
/
 
2
 
 transgene-positive embryonic day 18 pup
(Sugiyama et al., 1997) using the methods detailed by Donoghue et al.
(1992). Cells were cultured as myoblasts at 33
 
8
 
C in DME containing 10%
heat-inactivated FCS, glutamine, penicillin, streptomycin, and 20 U/ml
 
g
 
-interferon (R&D Systems, Inc.). To induce formation of myotubes, cul-
tures were transferred to 37
 
8
 
C and the medium was replaced with DME
containing 2% horse serum, glutamine, and antibiotics, but no FCS or in-
terferon. Cells were transfected as myoblasts with Fugene6 reagent
(Roche Molecular Biochemical), used according to the manufacturer’s in-
structions. Fusion was initiated 1 d after transfection and cultures were
harvested 5–7 d later. Between 5 and 20% of myotubes expressed the ex-
ogenous protein, as assessed by immunostaining.
For immunoblotting analysis, the cells were cultured on 10-cm plates.
In some experiments, a recombinant carboxy-terminal fragment of agrin
(
 
z
 
100 nM; y
 
 5 
 
4, z
 
 5 
 
8 form; Ferns et al., 1993) was added to the cultures
for 10 min before harvesting. For immunohistochemistry, cells were cul-
tured on 13-mm-diam glass coverslips. Where specified, the recombinant
agrin fragment was added to the cultures for 18 h before harvesting.
The quail fibroblast cell line QT-6 (Moscovici et al., 1977) was obtained
from the American Type Culture Collection and cultured in DME con-
taining 10% FCS, 1% DMSO, penicillin, and streptomycin. Cells were cul-
tured on glass coverslips and transfected using the calcium phosphate
method described by Phillips et al. (1991b).
 
Immunoblotting
 
Cultured cells were lysed and solubilized in NP-40, the extracts were sub-
jected to immunoprecipitation with antibodies to MuSK and the resulting
precipitates were immunoblotted with antibodies to phosphotyrosine
(4G10; Upstate Biotechnology Inc.). After detection of the phosphory-
lated species, the immunoblots were stripped and reprobed with antise-
rum to the MuSK cytoplasmic domain (see below) to ascertain total
MuSK levels.
 
Immunohistochemistry
 
MuSK
 
2/2
 
 myotubes were incubated live for 1 h with rhodamine-
 
a
 
-bunga-
rotoxin (rBTX; Molecular Probes, Inc.), washed, and fixed for 20 min at
room temperature in 2% paraformaldehyde in PBS. In some experiments, 
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cells were permeabilized by incubation for 10 min in 1% Triton X-100.
Nonspecific binding sites were blocked by overnight incubation with 10%
FCS at 4
 
8
 
C and then cultures were incubated sequentially with antibodies
to MuSK (for 2 h) and fluorescein-conjugated second antibody (for 1 h).
AChR clusters were counted with rhodamine illumination using a 40
 
3
 
 oil
objective. 10 fields were chosen at random on each coverslip, all clusters
 
.
 
3 
 
m
 
m in diameter were counted, and this number was divided by the
number of myotubes that crossed the field.
QT-6 cells were rinsed in PBS, fixed in 1% paraformaldehyde, 100 mM
 
L
 
-lysine, and 10 mM sodium metaperiodate, rinsed again, and permeabi-
lized with 1% Triton X-100. They were incubated with a mixture of mouse
anti-rapsyn (Peng and Froehner, 1985) and rabbit anti-MuSK, washed,
and reincubated with a mixture of fluorescein- and rhodamine-conjugated
second antibodies.
Rabbit antisera were generated to the cytoplasmic domain (serum
41101K) and to the ectodomain of rat MuSK, using standard techniques
(Glass et al. 1996). Antiserum to a soluble fusion between the ectodomain
of mouse MuSK and immunoglobulin Fc segment (Meier et al. 1997) was
a gift of M. Ruegg (Basel, Switzerland).
 
Results
 
An Assay for MuSK Function
 
When myoblasts fuse to form myotubes, AChR subunit
genes are activated and AChRs synthesized. Most of the
receptors are diffusely distributed at low density on the
myotube surface, but some form high density aggregates,
which are readily visualized with the selective ligand rBTX
 
(Fig. 1 a). Addition of a recombinant carboxy-terminal
fragment of agrin increased the number of such AChR
clusters 
 
z
 
10-fold (Fig. 1 b). In contrast, myoblasts derived
from 
 
MuSK
 
2
 
/
 
2
 
 mutant mice form myotubes that are unre-
sponsive to agrin, even though they bear normal levels of
diffuse AChRs (Glass et al., 1996). Likewise, myotubes of
an immortalized myogenic cell line derived from 
 
MuSK
 
2
 
/
 
2
 
muscle did not form AChR clusters, either spontaneously
or in response to agrin (Fig. 1, c and d). These results are
consistent with the notion that MuSK is a critical compo-
nent of the agrin receptor and that even spontaneous
AChR clusters are dependent on MuSK.
To establish an assay for MuSK function, we transfected
 
MuSK
 
2
 
/
 
2
 
 myoblasts with an expression vector encoding
rat MuSK, induced fusion, incubated the myotubes with or
without agrin, then stained them with rBTX. MuSK-trans-
fected myotubes formed a small number of clusters in the
absence of exogenous agrin, and approximately eightfold
more clusters in the presence of agrin (Fig. 1, e and f).
AChR clusters were present only on those myotubes that
had been transfected and were expressing MuSK (Fig.
1, i and j), and over 80% of MuSK-positive myotubes
in the agrin-treated cultures bore AChR clusters (data
not shown). Thus, spontaneous as well as agrin-induced
AChR clustering requires MuSK. Because 
 
MuSK
 
2
 
/
 
2
 
 myo-
tubes form AChR clusters in response to other, possibly
Figure 1. MuSK restores the ability of MuSK2/2 myotubes to
cluster AChRs spontaneously and in response to agrin. Myo-
blasts from wild-type mice (a and b) or from a MuSK2/2 myo-
genic cell line (c–j) were fused to form myotubes, treated with
agrin (b, d, f, and h–j) or left untreated (a, c, e, and g) for 18 h,
and then stained with rBTX (a–i) or anti-MuSK (j). (a and b)
Wild-type myotubes formed small numbers of AChR clusters
spontaneously and many more after treatment with recombi-
nant agrin. (c and d) MuSK2/2 myotubes formed neither spon-
taneous nor agrin-induced AChR clusters. (e and f) Transfec-
tion of MuSK2/2 cells with rat MuSK restores their ability to
form small numbers of spontaneous and large numbers of
agrin-induced AChR clusters. (g and h) Transfection with a
Torpedo receptor tyrosine kinase also rescues spontaneous and
agrin-induced clustering, suggesting that this MuSK homo-
logue is also a MuSK orthologue. (i and j) After transfection
with rat MuSK and agrin treatment, this culture was doubly
stained with rBTX and anti-MuSK. AChR clusters formed on
the MuSK-positive myotube, but remained diffusely distrib-
uted on adjacent, MuSK-negative myotubes. Bar, 20 mm. 
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nonphysiological, clustering agents (Sugiyama et al., 1997;
Gautam et al., 1999), we believe that MuSK is not required
as a structural component of AChR clusters. Instead,
spontaneous clustering is likely to result from a low level
of MuSK activation, either by an endogenous ligand or in
the absence of ligand. Data that distinguish these alterna-
tives are presented below.
To test the specificity of the response to agrin, we intro-
duced two other kinases into 
 
MuSK
 
2
 
/
 
2
 
 
 
myotubes: rat trkC
(Lamballe et al., 1991) and a receptor tyrosine kinase iso-
lated from 
 
Torpedo
 
 electric organ (Jennings et al., 1993).
TrkC, the receptor for neurotrophin 3 is homologous to
MuSK in its cytoplasmic domain, but unrelated in its ex-
tracellular domain. In contrast, the 
 
Torpedo
 
 kinase is ho-
mologous to MuSK throughout its length and is selectively
expressed in muscle; therefore, it is a plausible MuSK
orthologue. Myotubes transfected with trkC formed no
AChR clusters either spontaneously or in response to
neurotrophin 3, whereas the 
 
Torpedo
 
 kinase endowed
 
MuSK
 
2
 
/
 
2
 
 myotubes with the ability to form AChR clus-
ters spontaneously and in response to agrin (Fig. 1, g and
h, and data not shown). This result, combined with the in-
activity of trkC in this assay, supports the presumption
that the 
 
Torpedo
 
 kinase is orthologous to MuSK; we call it
 
Torpedo
 
 MuSK hereafter. Together, these results confirm
a specific requirement of MuSK for agrin signaling. More
important for the present study, the ability of MuSK to re-
store agrin sensitivity to 
 
MuSK
 
2
 
/
 
2
 
 cells provides an assay
system to determine the relationship between MuSK’s
structure and its function.
 
A Domain Required for Agrin to Activate MuSK
 
The extracellular segment of MuSK contains five distinct
domains: four immunoglobulin-like domains and a cys-
teine rich region called a C6 box. All five domains are con-
served in sequence and arrangement in rat, mouse, human,
 
Xenopus
 
, chicken, and 
 
Torpedo
 
 MuSK (Jennings et al.,
1993; Ganju et al., 1995; Valenzuela et al., 1995; Fu et al.,
1999; D.J. Glass, and G.D. Yancopoulos, unpublished). To
determine which portions of the MuSK ectodomain are re-
quired for its activation, we generated the mutants dia-
grammed in Fig. 2 a. In a first series (constructs 2–6), se-
quences were deleted that encoded either the first, second,
or third immunoglobulin-like domain, the C6 box, or the
fourth immunoglobulin-like domain. In a second series
(constructs 7–13), nested deletions extended variable dis-
tances toward the amino terminus from a common site just
Figure 2. Amino-terminal regions in
the MuSK ectodomain are required to
mediate agrin-dependent AChR clus-
tering. (a) Mutant constructs. The top
line shows motifs in the MuSK
ectodomain, including four immuno-
globulin-like domains (Ig I–IV) and a
region containing six phylogenetically
conserved cysteine residues (C6). Sub-
sequent lines show structures of wild-
type and mutant constructs tested by
expression in MuSK2/2 myotubes. To
the right of each construct is indicated
whether or not it rescued the ability of
MuSK2/2 myotubes to form AChR
clusters in the absence of agrin (2Ag)
or to form additional clusters in the
presence of agrin (1Ag). All mutants
permitted spontaneous clustering (1),
but mutants lacking amino-terminal re-
gions (Ig-I and -II) were unable to re-
spond to agrin (5, spontaneous level
of clustering; ­, reduced relative to
wild-type; ­­, wild-type level of clus-
tering). (b–g) Examples of AChR clus-
ters on MuSK2/2myotubes that had
been transfected with mutant con-
structs, treated, and stained as in Fig. 1.
(b and c) Construct 2. (d and e) Con-
struct 3. (f and g) Construct 10. (h)
Quantitation of the extent to which
MuSK constructs 1, 2, and 3 rescued
the ability of MuSK2/2 myotubes to
form AChR clusters in the absence or
presence of agrin. Cultures were dou-
bly stained with rBTX and anti-MuSK
as in Fig. 1 (i and j), and only MuSK-
positive (i.e., successfully transfected)
myotubes were scored. Bar is 20 mm. 
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upstream of the predicted transmembrane domain. Each
mutant, as well as wild-type MuSK (construct 1), was
transfected into 
 
MuSK
 
2
 
/
 
2
 
 myoblasts, which were fused,
treated, and stained as described above.
Four principal results were obtained from this series of
experiments. First, all of the constructs restored the ability
of 
 
MuSK
 
2
 
/
 
2
 
 myotubes to form spontaneous AChR clus-
ters (Fig. 2, b, d, and f). Because the deletions span the en-
tire ectodomain, we conclude that spontaneous clustering
reflects ligand-independent activation of MuSK rather
than activation by an endogenous ligand.
Second, all of the mutants with deletions confined to the
carboxy-terminal three fifths of the ectodomain were able
to mediate agrin-induced AChR clustering (Fig. 2, f and g,
constructs 4–11). We did not rigorously control for differ-
ences in transfection efficiency, but conclude that differ-
ences between any of these mutants and wild-type MuSK
were less than twofold. Thus, the third and fourth immu-
noglobulin domains and the C6 box are dispensable for
agrin-mediated AChR clustering. Interestingly, Hesser et
al. (1999) recently reported on the occurrence of a natu-
rally occurring splice variant of MuSK that lacks the third
immunoglobulin-like repeat, yet retains the ability to in-
duce AChR clustering.
Third, mutants with deletions in the amino-terminal two
fifths of the ectodomain were markedly impaired in their
ability to mediate agrin-induced AChR clustering (Fig. 2,
b–e, constructs 2, 3, 12, and 13). This inability did not re-
sult from failure of these mutants to reach the cell surface,
because staining of nonpermeabilized cells with antibodies
to MuSK showed clear immunoreactivity (see below).
Thus, sequences in or near the first or second immuno-
globulin-like domain interact, directly or indirectly, with
agrin.
Fourth, whereas mutants lacking sequences within the
first immunoglobulin-like domain (constructs 2 and 13)
were completely agrin-insensitive, agrin had limited ability
to stimulate AChR clustering (
 
z
 
2.5-fold above spontane-
ous levels) in myotubes transfected with mutants lacking
the second immunoglobulin-like domain (Fig. 2 h, con-
structs 3 and 12, and data not shown; only transfected
[MuSK-positive] myotubes were scored). The difference
between constructs 2 and 13 on the one hand and con-
structs 3 and 12 on the other indicates that sequences in or
near immunoglobulin-like domain 1 are sufficient to en-
dow MuSK with agrin responsiveness.
 
Agrin-dependent Tyrosine Phosphorylation of MuSK 
Ectodomain Mutants
 
Previous studies have shown that agrin causes rapid phos-
phorylation of MuSK, and that this phosphorylation is
required for MuSK to mediate agrin’s effects (Glass et
al., 1996, 1997; Meier et al., 1996). If this is so, MuSK
ectodomain mutants able to mediate agrin-induced AChR
clustering should exhibit agrin-dependent phosphoryla-
tion. To test this prediction, we assayed agrin-dependent
phosphorylation of MuSK. Wild-type or mutant MuSK
was precipitated from lysates of transfected 
 
MuSK
 
2
 
/
 
2
 
 cells
with an antibody to an intracellular epitope, which was
present in all mutants. Precipitated material was separated
by gel electrophoresis, transferred to nitrocellulose, and
probed with antiphosphotyrosine antibody. The blots were
stripped and reprobed with anti-MuSK, to permit normal-
ization to MuSK protein levels and to confirm the electro-
phoretic mobility of the mutants.
As shown in Fig. 3, MuSK was undetectable in untrans-
fected 
 
MuSK
 
2
 
/
 
2
 
 cells, but readily detectable in transfected
cells. Wild-type MuSK was phosphorylated at a low level
in the absence of added agrin, and its phosphorylation was
increased 
 
.
 
10-fold 10 min after the addition of agrin to
Figure 3. Tyrosine phosphorylation of MuSK ectodomain mu-
tants. MuSK2/2 myotubes were transfected with the indicated
constructs (Fig. 2 a), treated with agrin for 10 min (1) or left un-
treated (2), and then subjected to immunoprecipitation with
anti-MuSK. Immunoblots were probed with antiphosphotyrosine
(a), stripped, and reprobed with anti-MuSK (b). (lanes 1 and 2)
Untransfected myoblasts; (lanes 3 and 4) myoblasts transfected
with wild-type MuSK (construct 1); (lanes 5 and 6) myoblasts
transfected with construct 11; and (lanes 7 and 8) myoblasts
transfected with construct 13. Wild-type MuSK and construct 11,
both of which mediate agrin-induced AChR clustering, also show
agrin-dependent tyrosine phosphorylation. Mutant 13, which
does not mediate agrin-dependent tyrosine phosphorylation,
shows a high level of agrin-independent phosphorylation but
only slight agrin-dependent phosphorylation.The Journal of Cell Biology, Volume 146, 1999 1138
the cells (lanes 3 and 4). Tyrosine phosphorylation of con-
struct 11 (which lacks immunoglobulin-like domains 3 and
4 and the C6 box yet remains responsive to agrin) was also
greatly stimulated by agrin (lanes 5 and 6). In contrast,
construct 13, which lacks most of the ectodomain and is
agrin unresponsive, was highly phosphorylated in the ab-
sence of agrin and showed only slightly increased phos-
phorylation after treatment with agrin (lanes 7 and 8). This
result raises the possibility that the ectodomain of MuSK
keeps the cytoplasmic domain inactive in the absence of
agrin; ligand binding would alter the conformation of the
ectodomain to relieve the inhibition.
A Domain Required for MuSK to Cocluster
with Rapsyn
MuSK and rapsyn cocluster when coexpressed in QT6 fi-
broblasts (Gillespie et al., 1996; Apel et al., 1997). Surpris-
ingly, even though rapsyn is a cytoplasmic protein, it is the
ectodomain of MuSK that is essential for this association:
chimeras composed of the ectodomain of MuSK and the
cytoplasmic domain of trkC cocluster with rapsyn in QT6
cells, whereas chimeras containing the ectodomain of trkC
and the cytoplasmic domain of MuSK do not (Apel et al.,
1997). Therefore, we hypothesized that RATL mediates
the association.
We asked whether the portions of MuSK required for
association with rapsyn were distinguishable from those
required for activation by agrin. For this purpose, we mod-
ified construct 2, which lacks the first immunoglobulin-like
domain and is agrin unresponsive. In construct 2T (Fig. 4
a), the ectodomain from construct 2 was fused to the trans-
membrane and cytoplasmic domains of trkC, to exclude
any contribution of cytoplasmic MuSK sequences to its lo-
calization. We used trkC as a negative control and the chi-
mera between wild-type MuSK and trkC (construct 1T) as
a positive control. These constructs were transfected into
QT-6 cells either alone or with an expression vector en-
coding rapsyn. 2 d later, cells were fixed, permeabilized,
and doubly stained with antibodies specific for rapsyn and
MuSK or trkC. Rapsyn formed small aggregates when
transfected by itself, whereas construct 1T, construct 2T,
and trkC were all diffusely distributed when introduced
alone (Fig. 4, b and c, and data not shown). Cotransfection
of rapsyn and trkC had no effect on the distribution of ei-
ther component, whereas cotransfection of rapsyn with
constructs 1T or 2T led to nearly perfect colocalization of
the two components in most cells (Fig. 4, d–g, and data not
shown). No differences were detected between constructs
1T and 2T in this assay. Thus, sequences required for acti-
vation by agrin are not required for colocalization with
rapsyn.
Based on these results, we generated and tested con-
structs in which additional sequences were deleted. Con-
structs 14T and 15T, in which immunoglobulin-like do-
mains 1 and 2 or 1–3, respectively, were deleted behaved
like constructs 1T and 2T in this assay: they were diffusely
distributed when introduced on their own, but coclustered
with rapsyn when both components were expressed (Fig.
4 a). In contrast, constructs 5T and 6T, which lacked
carboxy-terminal portions of the ectodomain (the C6
box and the fourth immunoglobulin-like domain, respec-
tively), were diffusely distributed both in the absence and
in the presence of rapsyn (Fig. 4, h and i, and data not
shown). For each construct, similar results were obtained
when AChR subunits were cotransfected along with
rapsyn. That is, constructs 1T, 2T, 14T, and 15T aggre-
gated with rapsyn and AChRs, whereas 5T and 6T did not
(data not shown). Thus, juxtamembranous portions of the
MuSK ectodomain are required for its association with
rapsyn, presumably via RATL.
Together, the results in Figs. 2 and 4 show that se-
quences in the MuSK ectodomain required for colocaliza-
tion with rapsyn are dispensable for activation by agrin.
What role might this juxtamembranous region play in
muscle cells? One obvious possibility is that it is required
for the association of MuSK with AChR rich aggregates.
To test this hypothesis, we transfected MuSK2/2 cells with
MuSK mutants, and then stained nonpermeabilized cells
with anti-MuSK and rBTX to determine whether the
MuSK constructs reached the cell surface and whether
they colocalized with AChRs. As shown in Fig. 5, con-
structs that contained the fourth immunoglobulin-like do-
main of the MuSK ectodomain (constructs 1, 2, 4, and 5)
were concentrated at AChR clusters. In contrast, the two
constructs that lacked sequences within the fourth immu-
noglobulin-like domain (constructs 6 and 7) were present
on the myotube surface, but not concentrated at signifi-
cantly higher levels in AChR rich than in AChR poor ar-
eas. Thus, the domain required for MuSK to associate with
rapsyn in QT-6 cells is required for association with
rapsyn–AChR clusters in myotubes.
Two results from this series deserve further comment.
First, cells transfected with construct 2 were unresponsive
to agrin, but MuSK was concentrated at spontaneous clus-
ters in these cells; likewise MuSK was present at both
spontaneous and agrin-induced AChR clusters in cells
transfected with constructs 1, 4, and 5. Thus, the associa-
tion of MuSK with rapsyn in muscle cells does not require
that MuSK be activated by agrin. Second, construct 5T,
which lacked the C6 box, failed to colocalize with rapsyn
and AChRs in QT-6 cells but construct 5 did do so in myo-
tubes. We speculate that deletion of sequences adjacent to
the fourth immunoglobulin-like domain prevented that
domain from assuming an appropriate conformation in
heterologous cells but not in muscle cells.
Essential Binding Sites for ATP and for PTB
Domain-containing Proteins
How does agrin-induced phosphorylation of MuSK lead to
postsynaptic differentiation? According to a widely ac-
cepted model (for review see Schlessinger and Ullrich,
1992), phosphorylation activates multiple signal transduc-
tion pathways that eventually combine to generate the bi-
ological response. The signal transduction components are
recruited to the kinase by adaptor proteins that bind to
conserved sequences. Therefore, one strategy for defining
the pathways through which MuSK signals, is to identify
critical sites in its cytoplasmic domain.
As a first step, we tested a construct in which a critical
lysine residue in the consensus ATP binding site was re-
placed with alanine (Fig. 6 a, construct 16). Such mutations
in other receptor tyrosine kinases abolish tyrosine kinaseZhou et al. Structure–function Analysis of MuSK 1139
activity (Chou et al., 1987; Honegger et al., 1987), and we
showed previously that this MuSK mutant inhibits AChR
clustering when expressed in wild-type myotubes (Glass et
al., 1997), suggesting that it had reduced activity. There-
fore, if MuSK is acting as a receptor tyrosine kinase, con-
struct 16 should be unable to mediate AChR clustering.
Alternatively, if MuSK were only a substrate for other ki-
nases, this mutation might not abolish activity. Here, we
transfected construct 16 into MuSK2/2 cells, and then as-
sayed for tyrosine phosphorylation of the mutant by
immunoblotting and AChR clustering by staining with
rBTX. Construct 16 was devoid of detectable phosphoty-
rosine (Fig. 7, lanes 1 and 2) and was completely unable to
induce formation of AChR clusters, either spontaneously
or in response to agrin. Inactivity did not reflect poor ex-
pression or misrouting because construct 16 was expressed
at levels similar to those of wild-type MuSK and reached
the cell-surface without impediment (data not shown).
These results indicate that the kinase activity of MuSK is
essential for its biological activity.
Next, we tested the function of the cytoplasmic se-
quence NPMY, which is perfectly conserved among rat,
mouse, human, Xenopus, and Torpedo MuSKs (Jennings
et al., 1993; Valenzuala et al., 1995; Ganju et al., 1995; Fu
et al., 1999), and which corresponds to a consensus binding
site (NPXY) for signaling proteins that contain a PTB do-
Figure 4. Carboxy-terminal regions of the MuSK
ectodomain are required for association with rap-
syn in heterologous cells. (a) MuSK constructs
tested for their ability to cocluster with rapsyn in
QT-6 cells. In all constructs, the ectodomain was
derived from MuSK and the transmembrane and
cytoplasmic domains were derived from TrkC.
Abbreviations are as in Fig. 2, and areas of the
MuSK ectodomain included in constructs 1T, 2T,
5T, and 6T are identical to those in 1, 2, 5, and 6,
respectively, in Fig. 2. To the right of each con-
struct is indicated whether it coclustered with
rapsyn in QT-6 cells. (b–i) Localization of MuSK
and rapsyn in cells transfected with expression
vectors encoding MuSK construct 1T alone, (b
and c) rapsyn plus MuSK constructs that coclus-
ter well (d and e, 1T; f and g, 2T), or rapsyn plus
a MuSK construct that does not cocluster (h and
i, 6T). Cells were doubly stained with antibodies
specific for MuSK (b, d, f, and h) and rapsyn (c,
e, g, and i). Bar, 10 mm.The Journal of Cell Biology, Volume 146, 1999 1140
main (for review see van der Geer and Pawson, 1995; Borg
and Margolis, 1998). We changed the critical tyrosine resi-
due to phenylalanine (construct 17), a mutation known to
abolish binding of most PTB domain proteins. This muta-
tion had no detectable effect on the expression level or the
ability of MuSK to reach the cell surface (Fig. 8 d). How-
ever, myotubes transfected with construct 17 formed nei-
ther spontaneous nor agrin-induced AChR clusters (Fig. 6,
d, e, and h). Moreover, construct 17 was not detectably
phosphorylated either spontaneously or after addition of
agrin (Fig. 7, lanes 3 and 4). These results suggest that PTB
domain–containing proteins are required for activation of
MuSK’s kinase activity.
Muscle fibers express at least two PTB domain proteins,
insulin receptor substrate 1 (IRS-1) and shc (Araki et al.,
1993; Giorgino et al., 1995; Altiok et al., 1997). To deter-
mine whether either of these was activated by MuSK, we
incubated wild-type myotubes with or without agrin, im-
munoprecipitated IRS-1 or shc, and probed immunoblots
with antiphosphotyrosine. Neither protein was detectably
phosphorylated in response to agrin treatment (data not
shown). These results raised the possibility that MuSK as-
sociates with PTB proteins other than IRS-1 or shc. In sup-
port of this possibility, MuSK lacks residues upstream of
NPXY that favor interaction with IRS-1 or shc. Although
all PTB domains recognize the NPXY motif, residues
amino-terminal of this tetrapeptide dictate binding speci-
ficity. A hydrophobic residue such as I or L is present five
residues upstream of Y in sites that bind shc, and L is
present eight residues upstream of Y in sites that bind
Figure 5. Carboxy-terminal regions of the MuSK
ectodomain are required for association with
AChR clusters in myotubes. (a) MuSK constructs,
numbered as in Fig. 2, which were tested for their
ability to associate with AChR clusters in MuSK2/2
muscle cells. To the right of each construct is indi-
cated whether it was concentrated at spontaneous
or agrin-induced clusters. NA, not applicable, be-
cause agrin did not induce AChR clusters in these
cells. (b–i) MuSK and AChR localization in cells
transfected with expression vectors encoding
MuSK constructs that colocalize (b and c, construct
1; d and e, construct 2; f and g, construct 5) or do
not colocalize (h and i, construct 6) with AChRs.
Cells were treated with agrin for 18 h, and then
doubly stained with anti-mouse MuSK antibodies
(b, d, f, and h) and rBTX (c, e, g, and i). Arrows in-
dicate corresponding points in the two images of
each field. Bar, 20 mm.Zhou et al. Structure–function Analysis of MuSK 1141
IRS-1 (Gustafson et al., 1995; Eck et al., 1996; Kuriyan and
Cowburn, 1997; Borg and Margolis, 1998; Cattaneo and
Pelicci, 1998). In rat, mouse, human, Xenopus, and Tor-
pedo MuSKs, the fifth and eighth residues are H and D,
respectively, so the extended sequence (DRLHPNPMY)
would not be expected to bind either shc or IRS-1.
To assess the importance of the sequence upstream of
NPMY in MuSK (DRLHP), we altered it either to LYLSS
(construct 18), which is found upstream of NPXY in the
IRS-1 binding site of the insulin receptor, or to IPILE
(construct 19), which is upstream of NPXY in the shc bind-
ing site of trkB and trkC. Both of these constructs medi-
ated agrin-dependent AChR clustering, but at lower levels
than wild-type MuSK (Fig. 6, a and f–h). In addition, con-
struct 18 was poorly phosphorylated in response to agrin
(Fig. 7, lanes 5 and 6). The fact that residues adjacent to
the NPXY motif modulate MuSK activity supports the
idea that PTB domain proteins are involved in MuSK sig-
naling. However, the finding that optimizing the MuSK
cytoplasmic domain to bind shc or IRS-1 decreased the
ability of MuSK to induce AChR clustering suggests that
wild-type MuSK interacts with a PTB domain protein that
is neither shc nor IRS1.
Inessential Binding Sites for
Phosphatidylinositol-3-kinase and PDZ
Domain Proteins
The essential ATP- and PTB domain–binding sites of MuSK
are within the amino-terminal third of its cytoplasmic do-
main. To ask whether the carboxy-terminal portion of the
cytoplasmic domain also contained essential sites, we de-
leted the last 214, 148, or 70 amino acids (Fig. 8 a, con-
structs 21–23). All three of these constructs were com-
pletely inactive in the presence or absence of agrin (data
not shown), suggesting that sites in the carboxy-terminal
fifth of the cytoplasmic domain were essential for activity.
Examination of the sequence revealed two consensus
binding sites in this region. The first was YXXM, which is
the consensus binding site for p85, the regulatory subunit
of phosphatidylinositol-3-kinase. This enzyme mediates
signal transduction by several tyrosine kinases, including
the trk kinases which, as noted above, are related to
MuSK (Songyang et al., 1993; for review see Fruman et al.,
1998). The second was VXV at the carboxy terminus,
which resembles the consensus binding site for PDZ do-
main proteins. Proteins in this family that have been impli-
cated in the aggregation of numerous membrane proteins
include components of the postsynaptic membrane such as
glutamate receptors and ephrins (Fanning and Anderson,
1998; Hata et al., 1998; O’Brien et al., 1998; Torres et al.,
1998). Moreover, using the yeast two-hybrid system, we
have identified PDZ domain proteins that bind to MuSK,
and shown that deletion of its carboxy-terminal three resi-
dues abolishes the ability of MuSK to bind these proteins
(Torres, R., E.D. Apel, H. Zhou, D.J. Glass, J.R. Sanes,
and G.D. Yancopoulos, unpublished observations).
We changed the essential tyrosine of the putative p85
Figure 6. Roles of binding sites
for ATP and for PTB domain
proteins in the MuSK cytoplas-
mic domain. (a) Mutant con-
structs. To the right of each con-
struct is indicated whether or
not it rescued the ability of
MuSK2/2 myotubes to form
AChR clusters in the absence of
agrin (2Ag) or to form addi-
tional clusters in the presence of
agrin (1Ag). Plus sign, sponta-
neous clustering; 2, no cluster-
ing; ­­, wild-type level of agrin
sensitivity; and ­, reduced clus-
tering relative to wild-type. In
constructs 16 and 17, a con-
served ATP binding site and a
binding site for PTB domain
proteins, respectively, were mu-
tated. In constructs 18 and 19,
the specificity of the PTB site
was altered, as detailed in Re-
sults. (b–g) Distribution of
AChRs on MuSK2/2 myotubes
that had been transfected with
mutant constructs, treated, and
stained as in Fig 1. (b and c)
Construct 1; (d and e) construct
17; and (f and g) construct 19.
(h) Quantitation of the extent to which MuSK constructs 17, 18, and 19 rescued the ability of MuSK2/2 myotubes to form AChR clus-
ters in the absence or presence of agrin. Constructs 16 and 17 were inactive, whereas constructs 18 and 19 showed reduced activity rela-
tive to wild-type (compare with Figs. 2 h and 8 h). Cultures were doubly stained with rBTX and anti-MuSK, and only MuSK-positive
(i.e., successfully transfected) myotubes were scored. Bar, 20 mm.The Journal of Cell Biology, Volume 146, 1999 1142
binding site to phenylalanine in construct 24, and deleted
the carboxy-terminal three resides (VGV) in construct 25.
Surprisingly, both constructs were equivalent to wild-type
MuSK in their abilities to mediate spontaneous and agrin-
induced AChR clustering (Fig. 8, b, c, and h). Thus, both
the p85- and the PDZ domain–binding sites are dispens-
able for MuSK function in cultured myotubes. In view of
the similarity of MuSK to trk, it is interesting that the p85-
binding domain in trk is dispensable for at least some as-
pects of neurotrophin signaling (Hallberg et al., 1998). In
light of the known role of PDZ domain proteins in aggre-
gation of postsynaptic components, we also asked whether
construct 25 was impaired in its ability to associate with
AChR–rapsyn clusters. The association of this mutant
with AChRs and rapsyn in myotubes was indistinguishable
from that of wild-type MuSK (Fig. 8, f and g).
Discussion
Numerous polypeptides promote growth or differentia-
tion by binding to the ectodomain of receptor tyrosine ki-
nases. This binding induces dimerization or conforma-
tional changes that lead to autophosphorylation. Once
phosphorylated, the cytoplasmic domain recruits and/or
phosphorylates additional components that transduce the
biological signal (Schlessinger and Ullrich, 1992). In keep-
ing with this model, agrin interacts with and activates
MuSK, and MuSK phosphorylation is required for AChR
Figure 7. Tyrosine phosphorylation of MuSK cytoplasmic mu-
tants. MuSK2/2 myotubes were transfected with indicated con-
structs (Fig. 6 a), treated with agrin for 10 min (1), or left un-
treated (2), and then subjected to immunoprecipitation with
anti-MuSK. Immunoblots were probed with antiphosphotyrosine
(a), and then stripped and reprobed with anti-MuSK (b). Con-
structs 16 and 17, which do not mediate agrin-dependent tyrosine
phosphorylation, are not detectably phosphorylated. Constructs
18 and 19 mediate lower levels of agrin-induced AChR clustering
than wild-type MuSK; agrin-dependent tyrosine phosphorylation
is greatly reduced for construct 18 but not construct 19.
Figure 8. Binding sites predicted to
recognize p85 and PDZ domain-con-
taining proteins are inessential for
MuSK to cluster AChRs or to associate
with AChR clusters. (a) Mutant con-
structs. To the right of each construct is
indicated whether or not it rescued the
ability of MuSK2/2myotubes to form
AChR clusters in the absence of agrin
(2Ag) or to form additional clusters in
the presence of agrin (1Ag). 1, spon-
taneous clustering; 2, no clustering;
­­, wild-type level of agrin sensitivity;
and ­, reduced clustering relative to
wild-type. In constructs 20–23, large
segments of the cytoplasmic domain
were deleted. In constructs 24 and 25,
putative binding sites for p85 and PDZ
domains were mutated. Constructs 20–
23 were completely inactive, whereas
constructs 24 and 25 showed activity
equivalent to that of wild-type MuSK.
(b and c) Cells that had been trans-
fected with construct 25, incubated
with or without agrin, and then stained
with rBTX. (d–g) Cells that had been
transfected with construct 17 (d and e)
or 25 (f and g), treated with agrin, and
then doubly stained with rBTX (d and
f) and anti-MuSK antibodies (e and g).
The MuSK mutant with a three residue carboxy-terminal truncation (construct 25) is unable to bind PDZ domains in PICK (data not
shown) but can induce and associate with AChR clusters. MuSK and AChRs are both diffusely distributed in myotubes transfected with
construct 17. (h) Quantitation of the extent to which MuSK constructs 24 and 25 rescued the ability of MuSK2/2 myotubes to form
AChR clusters in the absence or presence of agrin. Cultures were doubly stained with rBTX and anti-MuSK, and only MuSK-positive
(i.e., successfully transfected) myotubes were scored. Bar, 20 mm.Zhou et al. Structure–function Analysis of MuSK 1143
clustering. However, agrin and MuSK are unusual among
growth factor/receptor tyrosine kinase pairs in at least two
respects. First, agrin does not bind MuSK directly, but re-
quires an accessory component, MASC (Glass et al.,
1996). Second, the ectodomain serves not only to activate
MuSK but also to recruit AChR–rapsyn aggregates, via
another accessory component, RATL (Apel et al., 1997).
Here, we have mapped the domains of the MuSK
ectodomain that mediate interactions with agrin–MASC
and rapsyn–RATL. In addition, we have taken the first
steps toward mapping the cytoplasmic domains through
which MuSK transduces its signals.
In initial studies, we characterized a MuSK2/2 myogenic
cell line and showed that introduction of rat MuSK or a
related Torpedo kinase rescued the ability of MuSK-
deficient myotubes to form AChR clusters, both spon-
taneously and in response to agrin. Although these
experiments were designed to establish an assay for struc-
ture–function analysis, they led to three novel conclusions.
First, the Torpedo receptor kinase first described by Jen-
nings et al. (1993) and later shown to be homologous to
MuSK (Valenzuela et al., 1995) is likely to be a true ortho-
logue of MuSK. Second, the requirement for MuSK is lim-
ited to muscle cells. Results in vivo had not excluded the
possibility that expression of MuSK was also required at
earlier stages of development or in other tissues to gen-
erate agrin-sensitive myotubes, but analysis of rescued
MuSK2/2 cells demonstrates that this is not the case.
Third, formation of spontaneous as well as agrin-induced
AChR clusters requires MuSK. In principle, MuSK might
be activated at low level in a ligand-independent fashion,
or muscles might produce an endogenous ligand. We favor
the hypothesis that activation is ligand-independent, based
on our inability to block spontaneous clustering by dele-
tion of any portion of the ectodomain.
Using MuSK2/2 cells as an assay system, we found that
the amino-terminal two fifths of the ectodomain is both
necessary and sufficient to confer agrin sensitivity on
MuSK: deletions within this region compromised agrin
sensitivity, whereas constructs lacking the remainder of
the ectodomain were fully agrin-sensitive. The possibility
that these sequences are required for basal MuSK function
was excluded by the observation that a construct lacking
them restored the ability of MuSK2/2 cells to form sponta-
neous AChR clusters. The critical region includes two im-
munoglobulin-like domains, which are known to mediate
ligand binding in numerous cell surface receptors. Thus,
these domains may interact with agrin, MASC, or both.
Further analysis suggests that the region of the first im-
munoglobulin-like domain is more critical than that of
the second immunoglobulin-like domain for interactions
with agrin. Deletion of sequences within the first immu-
noglobulin-like domain completely abolished agrin-sen-
sitivity (constructs 2 and 13), whereas deletion of the
second immunoglobulin-like domain left MuSK with sig-
nificant albeit impaired agrin sensitivity (constructs 3 and
12). One interpretation of these results is that only se-
quences in or near the first immunoglobulin-like domain
is required for agrin responsiveness, but its conformation
is altered by mutations in neighboring areas. Alterna-
tively, the second immunoglobulin-like domain may con-
tain sites that stabilize or enhance interactions of MuSK
with agrin–MASC. We cannot yet distinguish between
these alternatives.
Next, we attempted to determine which portions of
MuSK are necessary for it to associate with rapsyn. Al-
though rapsyn is entirely intracellular, we showed previ-
ously that MuSK–rapsyn interactions require the MuSK
ectodomain, implying the existence of a transmembrane
linker, RATL (Apel et al., 1997). Studies in both fibro-
blasts and MuSK2/2 myotubes suggest that the juxtamem-
branous portion of the ectodomain is both necessary and
sufficient for the association of MuSK and rapsyn–RATL:
MuSK fails to coaggregate with rapsyn in its absence,
whereas deletion of more amino-terminal sequences does
not impair MuSK–rapsyn coaggregation. The critical re-
gion includes the fourth immunoglobulin-like domain and
a unique juxtamembranous segment, either or both of
which might be involved in MuSK–rapsyn interactions; ad-
ditional constructs will be needed to distinguish these pos-
sibilities.
The observation that agrin induced AChR clustering in
constructs lacking the juxtamembranous domain showed
that MuSK–rapsyn/RATL interactions are dispensable for
at least some aspects of MuSK function. What roles might
such interactions play? We showed previously that MuSK-
dependent phosphorylation of AChRs is reduced in rap-
syn-deficient cells, which is consistent with the idea that
rapsyn and RATL bring AChRs into proximity with
MuSK (Apel et al., 1997). One possibility is that this inter-
action is more important in vivo than in the transfected
MuSK2/2 cells, which express MuSK at higher than nor-
mal levels. Alternatively, the requirement of rapsyn for
AChR phosphorylation may reflect a role of rapsyn
(which is present in MuSK2/2 cells) but not of MuSK–
rapsyn interactions. In either case, it is important to note
that AChR phosphorylation may not be required for
AChR clustering (Meyer and Wallace, 1998). Another
possibility, which we favor, is that MuSK–rapsyn interac-
tions (and possibly AChR phosphorylation) may be im-
portant for the localization of AChR clusters to synaptic
sites but not for their formation per se. Although it is natu-
ral to interpret our results on colocalization as reflecting
recruitment of MuSK to an AChR–rapsyn cluster, the rel-
evant interaction in vivo may be one that recruits AChR
and rapsyn to a subsynaptic concentration of MuSK. This
point is crucial in evaluating the model proposed below.
In a final series of studies, we initiated an analysis of the
MuSK cytoplasmic domain. Two observations from this
series were surprising. First, a binding site (NPXY) for
PTB domains in adaptor proteins (van der Geer and Paw-
son, 1995; Borg and Margolis, 1998) is required for MuSK
activity. This result was surprising because similar muta-
tions of other kinases such as trkB (Minichiello et al.,
1998) or erbB3 (Vijapurkar et al., 1998) impair but do not
abolish activity. Therefore, it will be important to learn
which PTB protein(s) bind(s) to MuSK, and what signal-
ing components they recruit to the complex. Second, a car-
boxy-terminal binding site (VXV) for PDZ domains in
scaffolding proteins (Fanning and Anderson, 1998) is dis-
pensable both for MuSK-activated AChR clustering and
for association of MuSK with AChR–rapsyn clusters. This
result was also unexpected in view of our evidence that
MuSK can bind PDZ proteins through its carboxy-termi-The Journal of Cell Biology, Volume 146, 1999 1144
nal VXV motif (Torres, R., E.D. Apel, H. Zhou, D.J.
Glass, J.R. Sanes, and G.D. Yancopoulos, unpublished ob-
servations) and that PDZ proteins play multiple roles in
assembly of the postsynaptic apparatus at neuron–neuron
synapses (Butz et al., 1998; Hata et al., 1998; O’Brien et al.,
1998; Torres et al., 1998). We favor the possibility that
PDZ domain proteins do play roles in MuSK signaling, but
that these roles are not readily detected in the assays we
have used to date.
Our new results, along with those presented previously
(Glass et al., 1996, 1997; Apel et al., 1997; Jones et al.,
1999), suggest a model in which MuSK plays critical roles
in three distinct steps that together lead to the formation
of the postsynaptic membrane (Fig. 9). First, a signal from
the nerve leads to formation of a primary synaptic scaffold
of which MuSK is a component, and for which MuSK is re-
quired (Gautam et al., 1995; Moscoso et al., 1995; deChi-
ara et al., 1996; Apel et al., 1997). The observation that
MuSK clusters beneath nerve terminals in rapsyn-defi-
cient mutant mice, whereas other components of the syn-
aptic membrane do not, demonstrates that the primary
scaffold is assembled by mechanisms distinct from those
responsible for AChR clustering. The neural signal that in-
duces formation of the primary scaffold is unknown; it
may be agrin, but no published data bear directly on this
point. Second, agrin released from the nerve terminal in-
teracts with MuSK, presumably via MASC, to activate
MuSK kinase. This interaction requires sequences in or
near the first immunoglobulin-like domain of MuSK, and
may also depend on the second immunoglobulin-like do-
main. Once phosphorylated, MuSK recruits PTB domain–
containing proteins to initiate a signaling process that
leads to formation of aggregates that contain AChRs, rap-
syn, and other components of the postsynaptic membrane
and cytoskeleton. Third, AChR–rapsyn clusters are re-
cruited to the primary scaffold. This step is mediated by
RATL, and requires juxtamembranous sequences of the
MuSK ectodomain. It is agrin-independent in that it is me-
diated by constructs unable to interact with agrin. Al-
though shown as a late step in the model, it probably oc-
curs in parallel with formation of the primary scaffold in
vivo (Noakes et al., 1993; Apel et al., 1997; Bowen et al.,
1998).
We believe this model is attractive because it accounts
for a cardinal difference between synaptogenesis and
other biological responses mediated by receptor tyrosine
kinases. MuSK-dependent aggregation of postsynaptic
specializations is not fundamentally different from other
kinase-dependent developmental programs. What is dif-
ferent is that MuSK localizes the specialized domain with
a submicron level of precision. By using separate accessory
proteins to catalyze formation of the postsynaptic appara-
tus and to recruit that apparatus to subsynaptic sites,
MuSK can independently control the composition and the
location of the synapse, both of which are critical for syn-
aptic function.
We thank E.D. Apel (Washington University) for valuable advice and
Figure 9. Model of MuSK-mediated postsynaptic dif-
ferentiation (see Discussion). In a first step, the nerve
induces subterminal clustering of MuSK, forming a pri-
mary synaptic scaffold. In a second step, nerve-derived
Z1 agrin activates MuSK, inducing coclustering of ra-
psyn and AChRs via intracellular pathways that in-
volve PTB domain–containing proteins but not PDZ
domain proteins. In a third step, MuSK uses RATL to
recruit rapsyn–AChR clusters to the primary scaffold.
Sequences in or near immunoglobulin-like domains 1
are required to mediate associations with agrin, pre-
sumably via MASC, whereas juxtamembranous se-
quences in or near immunoglobulin-like domain 4 are
required to mediate associations with rapsyn, presum-
ably via RATL.Zhou et al. Structure–function Analysis of MuSK 1145
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